Antibiotic therapy for lyme disease in a population-based cohort

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 694-695

  Peña, César A ^a,b   Mathews, Anita A ^a   Siddiqi, Nauman H ^a   Strickland, G Thomas ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Maryland State Department of Health and Mental Hygiene   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEPHALOSPORIN; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG COST; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HEALTH SURVEY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

EID: 0344994527     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598665     Document Type: Article

References (8)

1. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997;46(RR-10);20-1.
2. Strickland GT, Caisley I, Woubeshet M, Israel E. Antibiotic therapy for Lyme disease in Maryland, Public Health Rep 1994;109:745-9.
3. Steinberg SH, Strickland GT, Peña CA, Israel E, Lyme disease surveillance in Maryland, 1992. Ann Epidemiol 1996;6:24-9.
4. Rahn DW, Malawista SE. Lyme disease: recommendations for diagnosis and treatment. Ann Intern Med 1991;114:472-81.
5. Anonymous. Treatment of Lyme disease. Med Lett Drugs Ther 1992;34:95-7.
6. Anonymous, Treatment of Lyme disease. Med Lett Drugs Ther 1997;39:47-8.
7. Rahn DW, Evans J. Lyme disease. Philadelphia: American College of Physicians, 1998.
8. Coyle BS, Strickland GT, Liang YY, Peña CA, McCarter R, Israel E. The public health impact of Lyme disease in Maryland. J Infect Dis 1996;173:1260-2.